期刊文献+

PLGA微粒中蛋白稳定性和完全释放的研究进展 被引量:2

Stability and complete release of protein from PLGA-based microparticles: an update
下载PDF
导出
摘要 以PLGA为载体的蛋白药物微粒给药系统存在的最大的问题是蛋白稳定性和蛋白的完全释放。本文总结了增强蛋白药物稳定性和在体外释放期间促使蛋白完全释放的方法。蛋白药物完全释放的前提是保持蛋白稳定性。保持蛋白稳定性的方法之一是通过加入添加剂、对蛋白药物和聚合物进行修饰等避免蛋白在不利释放环境中聚集变性;另一个方法是避免不稳定环境的形成。 One of the most challenging issues in the delivery of therapeutic proteins from PLGA-based microparticles is the stability and complete release of the protein in its native form.This review summarizes the methods to promote the stability and in vitro release of protein from PLGA-based microparticles.Protein stability is the precondition of complete release.One way to keep protein stability is to use stabilizer or modify protein to avoid denaturation and aggregation;another way is to avoid the pro-instability environment.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2012年第3期328-331,共4页 Academic Journal of Second Military Medical University
基金 国家自然科学基金(81000689 81172514 30873178) 上海市自然科学基金(10ZR1437300)~~
关键词 蛋白 PLGA微粒 稳定性 药物释放系统 protein PLGA microspheres stability drug delivery systems
  • 相关文献

参考文献28

  • 1Kokai L E,Ghaznavi A M,Marra K G.Incorporation of double-walled microspheres into polymer nerve guides for the sustained de-livery of glial cell line-derived neurotrophic factor[J].Biomateri-als,2010,31:2313-2322.
  • 2Klose D,Siepmann F,Willart J F,Descamps M,Siepmann J.Drug release from PLGA-based microparticles:effects of the“microp-article:bulk fluid”ratio[J].Int J Pharm,2010,383(1-2):123-131.
  • 3Li Z,Li L,Liu Y,Zhang H,Li X,Luo F,et al.Development of in-terferon alpha-2b microspheres with constant release[J].Int J Pharm,2011,410(1-2):48-53.
  • 4Tse M T,Blatchford C,Oya Alpar H.Evaluation of different buffers on plasmid DNA encapsulation into PLGA microparticles[J].Int J Pharm,2009,370(1-2):33-40.
  • 5Hora M S,Rana R K,Nunberg J H,Tice T R,Gilley R M,Hudson M E.Release of human serum albumin from poly(lactide-co-gly-colide)microspheres[J].Pharm Res,1990,7:1190-1194.
  • 6Yang J,Cleland J L.Factors affecting the in vitro release of recombi-nant human interferon-gamma(rhIFN-gamma)from PLGA mi-crospheres[J].J Pharm Sci,1997,86:908-914.
  • 7Klose D,Delplace C,Siepmann J.Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles[J].Int J Pharm,2011,404(1-2):75-82.
  • 8Kim H K,Chung H J,Park T G.Biodegradable polymeric micro-spheres with“open/closed”pores for sustained release of human growth hormone[J].J Contr Rel,2006,112:167-174.
  • 9Elkharraz K,Ahmed A R,Dashevsky A,Bodmeier R.Encapsulation of water-soluble drugs by an o/o/o-solvent extraction microencap-sulation method[J].Int J Pharm,2011,409(1-2):89-95.
  • 10Kim H K,Park T G.Comparative study on sustained release of hu-man growth hormone from semi-crystalline poly(L-lactic acid)and amorphous poly(D,L-lactic-co-glycolic acid)micro-spheres:morphological effect on protein release[J].J Contr Rel,2004,98:115-125.

同被引文献18

  • 1Choktanasiri W,Boonkasemsantib W,Sittisomwongb T,et al.Long-acting triptorelin for the treatment of endometriosis[J].International Journal of Gynecology&Obstetrics,1996(54):237-243.
  • 2Simone Ferrero,Giovanni Camerini,Nicola Ragni,et al.Triptorelin improves intestinal symptoms among patients with colorectal endometriosis[J].Brief Communications,2009(10):250-251.
  • 3Kyonghee Park,Goo Young Jung,Myong-Ki Kim,et al.Triptorelin acetate-loaded poly(lactide-co-glycolide)(PLGA)microspheres for controlled drug delivery[J].Macromolecular Research,2012,20(8):847-851.
  • 4ANDERSON J M,SHIVE M S. Biodegradation and biocom- patibility of PLA and PLGA microspheres [ J ]. Adv Drug Deliv Rev,2012,64(Suppl) :72-82.
  • 5QI Feng, WU Jie, YANG Tingyuan, et al. Mechanistic studies for monodisperse exenatide-loaded PLGA microspheres prepared by different methods based on SPG membrane emulsification [ J 1. Acta Biomater, 2014,10 ( 8 ) : 4247-4256.
  • 6KLOSE D, SIEPMANN F,WILLART J F, et al. Drug release from PLGA-based microparticles : effects of the microparticle : bulk fluid ratio[J]. Int J Pharm,2010,383(1/2) :123-131.
  • 7PATEL B, GUPTA V, AHSAN F. PEG-PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin [ J ]. J Control Release, 2012,162 : 310-320.
  • 8BUSKE J, KONIG C, BASSARAB S, et al. Influence of PEG in PEG-PLGA microspheres on particle properties and protein release[ J]. Eur J Pharm Biopharm, 2012,81 ( 1 ) : 57-63.
  • 9CHEN Liang, CI Tianyuan, YU Lin, et al. Effects of molecular weight and its distribution of PEG block on micellization and thermogellability of PLGA-PEG-PLGA copolymer aqueous solutions[ J ]. Macromolecules, 2015,48 (11) :3662-3671.
  • 10LOUGUET S, VERRET V, BI~DOUET L, et ah Poly (ethylene glycol) methacrylate hydrolyzable microspheres for transient vascular embolization [ J ]. Acta Biomater, 2014, 10(5) :1194-1205.

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部